AN OPEN-LABEL, EXPLORATORY STUDY TO ESTABLISH THE EFFICACY AND SAFETY OF 1-YEAR CANAKINUMAB TREATMENT IN BEHCET'S DISEASE PATIENTS WITH NEUROLOGIC OR VASCULAR INVOLVEMENT

被引：0
|
作者：
Gul, A. [1 ]
Kurtuncu, M. [1 ]
Erdugan, M. [1 ]
Oguz, E. [1 ]
Gunduz, T. [1 ]
Demir, G. Akman [1 ]
Sevgi, S. [2 ]
Turgay, S. [2 ]
Acar, E. [2 ]
机构：
[1] Istanbul Fac Med, Istanbul, Turkey
[2] Novartis Turkey, Istanbul, Turkey
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.4247
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0480
引用
收藏
页码：1533 / 1534
页数：2
相关论文
共 50 条
  • [41] Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study
    Brunner, Hermine, I
    Quartier, Pierre
    Alexeeva, Ekaterina
    Constantin, Tamas
    Kone-Paut, Isabelle
    Marzan, Katherine
    Schneider, Rayfel
    Wulffraat, Nico M.
    Chasnyk, Vyacheslav
    Tirosh, Irit
    Kallinich, Tilmann
    Kuemmerle-Deschner, Jasmin
    Wouters, Carine
    Lauwerys, Bernard
    Nikishina, Irina
    Trachana, Maria
    Vougiouka, Olga
    Martini, Alberto
    Lovell, Daniel J.
    Levy, Jeremy
    Vritzali, Eleni
    Ruperto, Nicolino
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (12) : 2147 - 2158
  • [42] An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS1 hydromorphone in patients with chronic cancer pain
    Hanna M.
    Tuca A.
    Thipphawong J.
    BMC Palliative Care, 8 (1)
  • [43] Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study
    Tugal-Tutkun, Ilknur
    Kadayifcilar, Sibel
    Khairallah, Moncef
    Lee, Sung Chul
    Ozdal, Pinar
    Ozyazgan, Yilmaz
    Song, Ji Hun
    Yu, Hyeong Gon
    Lehner, Valerie
    de Cordoue, Agnes
    Bernard, Oana
    Gul, Ahmet
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2017, 25 (01) : 62 - 70
  • [44] An Open-Label Safety, Efficacy, and Pharmacodynamic Investigation of SYN118 in Patients with Parkinson's Disease
    Al-Tawil, N.
    Tedroff, J.
    Carlstrom, C.
    Hallstrom, Y.
    Varrone, A.
    Meya, U.
    MOVEMENT DISORDERS, 2010, 25 : S676 - S677
  • [45] Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial
    Davalos, Antoni
    Cobo, Erik
    Molina, Carlos A.
    Chamorro, Angel
    Angeles de Miquel, M.
    San Roman, Luis
    Serena, Joaquin
    Lopez-Cancio, Elena
    Ribo, Marc
    Millan, Monica
    Urra, Xabier
    Cardona, Pere
    Tomasello, Alejandro
    Castano, Carlos
    Blasco, Jordi
    Aja, Lucia
    Rubiera, Marta
    Gomis, Meritxell
    Renu, Arturo
    Lara, Blanca
    Marti-Fabregas, Joan
    Jankowitz, Brian
    Cerda, Neus
    Jovin, Tudor G.
    LANCET NEUROLOGY, 2017, 16 (05): : 369 - 376
  • [46] Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease
    Doody, RS
    Geldmacher, DS
    Gordon, B
    Perdomo, CA
    Pratt, RD
    ARCHIVES OF NEUROLOGY, 2001, 58 (03) : 427 - 433
  • [47] Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study
    Uchida, Haruhito A.
    Nakajima, Hirofumi
    Hashimoto, Masami
    Nakamura, Akihiko
    Nunoue, Tomokazu
    Murakami, Kazuharu
    Hosoya, Takeshi
    Komoto, Kiichi
    Taguchi, Takashi
    Akasaka, Takaaki
    Shiosakai, Kazuhito
    Sugimoto, Kotaro
    Wada, Jun
    ADVANCES IN THERAPY, 2022, 39 (11) : 5158 - 5175
  • [48] Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study
    Haruhito A. Uchida
    Hirofumi Nakajima
    Masami Hashimoto
    Akihiko Nakamura
    Tomokazu Nunoue
    Kazuharu Murakami
    Takeshi Hosoya
    Kiichi Komoto
    Takashi Taguchi
    Takaaki Akasaka
    Kazuhito Shiosakai
    Kotaro Sugimoto
    Jun Wada
    Advances in Therapy, 2022, 39 : 5158 - 5175
  • [49] Efficacy and Safety of OnabotulinumtoxinA in an Open-Label Study for the Prophylactic Treatment of Chronic Migraine in Adult Patients: COMPEL
    Blumenfeld, Andrew
    Stark, Richard
    Adams, Aubrey Manack
    Orejudos, Amelia
    Aurora, Sheena
    NEUROLOGY, 2017, 88
  • [50] Efficacy and Safety of OnabotulinumtoxinA in an Open-Label Study for the Prophylactic Treatment of Chronic Migraine in Adult Patients: COMPEL
    Blumenfeld, Andrew
    Stark, Richard
    Adams, Aubrey Manack
    Orejudos, Amelia
    Aurora, Sheena
    NEUROLOGY, 2017, 88
12345